IsoPlexis Corporation
ISO · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $17 | $17 | $10 | $8 |
| % Growth | -2.9% | 66.1% | 38.4% | – |
| Cost of Goods Sold | $18 | $8 | $5 | $3 |
| Gross Profit | -$1 | $9 | $5 | $4 |
| % Margin | -5.5% | 50.8% | 52.1% | 56.6% |
| R&D Expenses | $24 | $21 | $11 | $10 |
| G&A Expenses | $43 | $26 | $8 | $5 |
| SG&A Expenses | $73 | $64 | $22 | $12 |
| Sales & Mktg Exp. | $30 | $38 | $14 | $8 |
| Other Operating Expenses | -$0 | $0 | -$4 | -$5 |
| Operating Expenses | $96 | $85 | $29 | $18 |
| Operating Income | -$101 | -$76 | -$23 | -$14 |
| % Margin | -604% | -442.2% | -223% | -181.4% |
| Other Income/Exp. Net | -$5 | -$5 | -$0 | -$0 |
| Pre-Tax Income | -$106 | -$82 | -$23 | -$14 |
| Tax Expense | $10 | $2 | $0 | $0 |
| Net Income | -$116 | -$84 | -$23 | -$14 |
| % Margin | -689.1% | -484.2% | -224.2% | -181.6% |
| EPS | -2.94 | -8.16 | -0.6 | -0.35 |
| % Growth | 64% | -1,260% | -71.4% | – |
| EPS Diluted | -2.94 | -8.16 | -0.6 | -0.35 |
| Weighted Avg Shares Out | 39 | 10 | 39 | 39 |
| Weighted Avg Shares Out Dil | 39 | 10 | 39 | 39 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $5 | $4 | $0 | $0 |
| Depreciation & Amortization | $10 | $1 | $1 | $0 |
| EBITDA | -$92 | -$77 | -$22 | -$13 |
| % Margin | -546.2% | -447.7% | -214.5% | -174.8% |